Vor Biopharma Stock Market Value
| VOR Stock | USD 1.08 0.03 2.70% |
| Symbol | Vor |
Vor Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vor Biopharma. If investors know Vor will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vor Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vor Biopharma is measured differently than its book value, which is the value of Vor that is recorded on the company's balance sheet. Investors also form their own opinion of Vor Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Vor Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vor Biopharma's market value can be influenced by many factors that don't directly affect Vor Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vor Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vor Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vor Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vor Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vor Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vor Biopharma.
| 01/01/2025 |
| 03/02/2025 |
If you would invest 0.00 in Vor Biopharma on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Vor Biopharma or generate 0.0% return on investment in Vor Biopharma over 60 days. Vor Biopharma is related to or competes with Monte Rosa, Design Therapeutics, Erasca, Edgewise Therapeutics, Adicet Bio, Cullinan Oncology, and Nuvalent. Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients More
Vor Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vor Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vor Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.57 | |||
| Information Ratio | 0.0887 | |||
| Maximum Drawdown | 63.37 | |||
| Value At Risk | (6.72) | |||
| Potential Upside | 17.86 |
Vor Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vor Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vor Biopharma's standard deviation. In reality, there are many statistical measures that can use Vor Biopharma historical prices to predict the future Vor Biopharma's volatility.| Risk Adjusted Performance | 0.0736 | |||
| Jensen Alpha | 0.8244 | |||
| Total Risk Alpha | 1.12 | |||
| Sortino Ratio | 0.1846 | |||
| Treynor Ratio | 5.91 |
Vor Biopharma Backtested Returns
Vor Biopharma appears to be dangerous, given 3 months investment horizon. Vor Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0768, which indicates the firm had a 0.0768 % return per unit of risk over the last 3 months. By inspecting Vor Biopharma's technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please review Vor Biopharma's Coefficient Of Variation of 1144.58, semi deviation of 4.14, and Risk Adjusted Performance of 0.0736 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vor Biopharma holds a performance score of 6. The entity has a beta of 0.14, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Vor Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vor Biopharma is expected to be smaller as well. Please check Vor Biopharma's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Vor Biopharma's existing price patterns will revert.
Auto-correlation | 0.24 |
Weak predictability
Vor Biopharma has weak predictability. Overlapping area represents the amount of predictability between Vor Biopharma time series from 1st of January 2025 to 31st of January 2025 and 31st of January 2025 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vor Biopharma price movement. The serial correlation of 0.24 indicates that over 24.0% of current Vor Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Vor Biopharma lagged returns against current returns
Autocorrelation, which is Vor Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vor Biopharma's stock expected returns. We can calculate the autocorrelation of Vor Biopharma returns to help us make a trade decision. For example, suppose you find that Vor Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vor Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vor Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vor Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vor Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Vor Biopharma Lagged Returns
When evaluating Vor Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vor Biopharma stock have on its future price. Vor Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vor Biopharma autocorrelation shows the relationship between Vor Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Vor Biopharma.
Regressed Prices |
| Timeline |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.